247 related articles for article (PubMed ID: 37848934)
1. SGLT2 inhibition, circulating metabolites, and atrial fibrillation: a Mendelian randomization study.
Li J; Yu Y; Sun Y; Yu B; Tan X; Wang B; Lu Y; Wang N
Cardiovasc Diabetol; 2023 Oct; 22(1):278. PubMed ID: 37848934
[TBL] [Abstract][Full Text] [Related]
2. SGLT1 and SGLT2 inhibition, circulating metabolites, and cerebral small vessel disease: a mediation Mendelian Randomization study.
Lv Y; Cheng X; Dong Q
Cardiovasc Diabetol; 2024 May; 23(1):157. PubMed ID: 38715111
[TBL] [Abstract][Full Text] [Related]
3. SGLT2 inhibition, high-density lipoprotein, and kidney function: a mendelian randomization study.
Wang Z; Wei J; Zhao W; Shi R; Zhu Y; Li X; Wang D
Lipids Health Dis; 2024 Mar; 23(1):84. PubMed ID: 38509588
[TBL] [Abstract][Full Text] [Related]
4. SGLT2 Inhibition, Choline Metabolites, and Cardiometabolic Diseases: A Mediation Mendelian Randomization Study.
Xu M; Zheng J; Hou T; Lin H; Wang T; Wang S; Lu J; Zhao Z; Li M; Xu Y; Ning G; Bi Y; Wang W
Diabetes Care; 2022 Nov; 45(11):2718-2728. PubMed ID: 36161993
[TBL] [Abstract][Full Text] [Related]
5. SGLT2 inhibitors and atrial fibrillation in type 2 diabetes: a systematic review with meta-analysis of 16 randomized controlled trials.
Li WJ; Chen XQ; Xu LL; Li YQ; Luo BH
Cardiovasc Diabetol; 2020 Aug; 19(1):130. PubMed ID: 32847602
[TBL] [Abstract][Full Text] [Related]
6. Diabetes mellitus, glycemic traits, SGLT2 inhibition, and risk of pulmonary arterial hypertension: A Mendelian randomization study.
Tan JS; Yang Y; Wang J; Wang Y; Lv T; Shu Y; Xu W; Chong L
Biosci Trends; 2024 Mar; 18(1):94-104. PubMed ID: 38325821
[TBL] [Abstract][Full Text] [Related]
7. Type 2 Diabetes and Atrial Fibrillation: Evaluating Causal and Pleiotropic Pathways Using Mendelian Randomization.
Reddy RK; Ardissino M; Ng FS
J Am Heart Assoc; 2023 Sep; 12(17):e030298. PubMed ID: 37609985
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Effect of Sodium-Glucose Cotransporter 2 Inhibition on Fracture Risk: Evidence From Mendelian Randomization and Genetic Association Study.
Dai H; Zheng L; Zhu Z; Geng X; Hou T; Wang Q; Zhu Y; Lin H; Wang S; Zheng R; Zhao Z; Li M; Lu J; Xu Y; Wang T; Liu J; Ning G; Wang W; Bi Y; Zheng J; Xu M
J Bone Miner Res; 2023 Nov; 38(11):1645-1653. PubMed ID: 37436694
[TBL] [Abstract][Full Text] [Related]
9. APOB and CCL17 as mediators in the protective effect of SGLT2 inhibition against myocardial infarction: Insights from proteome-wide mendelian randomization.
Shi L; Li G; Hou N; Tu L; Li J; Luo J; Hu S
Eur J Pharmacol; 2024 Aug; 976():176619. PubMed ID: 38679119
[TBL] [Abstract][Full Text] [Related]
10. Exploring the causal relationships and mediating factors between depression, anxiety, panic, and atrial fibrillation: A multivariable Mendelian randomization study.
Zhou H; Ji Y; Sun L; Wang Z; Jin S; Wang S; Yang C; Yin D; Li J
J Affect Disord; 2024 Mar; 349():635-645. PubMed ID: 38211754
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the Relationship Between Genetic Determinants of Thyroid Function and Atrial Fibrillation: A Mendelian Randomization Study.
Ellervik C; Roselli C; Christophersen IE; Alonso A; Pietzner M; Sitlani CM; Trompet S; Arking DE; Geelhoed B; Guo X; Kleber ME; Lin HJ; Lin H; MacFarlane P; Selvin E; Shaffer C; Smith AV; Verweij N; Weiss S; Cappola AR; Dörr M; Gudnason V; Heckbert S; Mooijaart S; März W; Psaty BM; Ridker PM; Roden D; Stott DJ; Völzke H; Benjamin EJ; Delgado G; Ellinor P; Homuth G; Köttgen A; Jukema JW; Lubitz SA; Mora S; Rienstra M; Rotter JI; Shoemaker MB; Sotoodehnia N; Taylor KD; van der Harst P; Albert CM; Chasman DI
JAMA Cardiol; 2019 Feb; 4(2):144-152. PubMed ID: 30673084
[TBL] [Abstract][Full Text] [Related]
12. Opposite causal effects of birthweight on myocardial infarction and atrial fibrillation and the distinct mediating pathways: a Mendelian randomization study.
Kong L; Wang Y; Ye C; Dou C; Liu D; Xu M; Zheng J; Zheng R; Xu Y; Li M; Zhao Z; Lu J; Chen Y; Wang W; Liu R; Bi Y; Wang T; Ning G
Cardiovasc Diabetol; 2023 Dec; 22(1):338. PubMed ID: 38087288
[TBL] [Abstract][Full Text] [Related]
13. Association of type 2 diabetes mellitus with the development of new-onset atrial fibrillation in patients with non-ischemic dilated cardiomyopathy: impact of SGLT2 inhibitors.
Tanaka H; Tatsumi K; Matsuzoe H; Soga F; Matsumoto K; Hirata KI
Int J Cardiovasc Imaging; 2021 Apr; 37(4):1333-1341. PubMed ID: 33392879
[TBL] [Abstract][Full Text] [Related]
14. The Relationship between Blood Lipids and Risk of Atrial Fibrillation: Univariable and Multivariable Mendelian Randomization Analysis.
Yang S; Pudasaini R; Zhi H; Wang L
Nutrients; 2021 Dec; 14(1):. PubMed ID: 35011056
[TBL] [Abstract][Full Text] [Related]
15. SGLT2 inhibition, circulating proteins, and insomnia: A mendelian randomization study.
Luo J; Tu L; Zhou C; Li G; Shi L; Hu S
Sleep Med; 2024 Jul; 119():480-487. PubMed ID: 38795402
[TBL] [Abstract][Full Text] [Related]
16. Causal effects of plasma lipids on the risk of atrial fibrillation: A multivariable mendelian randomization study.
Jiang Q; Qin D; Yang L; Lin Y; Zhai L; Zhang Y; Yang G; Wang K; Tong D; Li X; Chen Z; Huang K; Yu T; Xiang X; Cui C; Cai C; Shi J; Li M; Chen M
Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1569-1578. PubMed ID: 33814236
[TBL] [Abstract][Full Text] [Related]
17. Effect of Sodium-Glucose Cotransporter Inhibitors on Major Adverse Cardiovascular Events and Hospitalization for Heart Failure in Patients With Type 2 Diabetes Mellitus and Atrial Fibrillation.
Kwon CH; Kim YJ; Kim MJ; Cha MJ; Cho MS; Nam GB; Choi KJ; Kim J
Am J Cardiol; 2022 Sep; 178():35-42. PubMed ID: 35810007
[TBL] [Abstract][Full Text] [Related]
18. Genetic Evidence for Causal Association Between Atrial Fibrillation and Dementia: A Mendelian Randomization Study.
Li M; Jiang C; Lai Y; Wang Y; Zhao M; Li S; Peng X; He L; Guo X; Li S; Liu N; Jiang C; Tang R; Sang C; Long D; Du X; Dong J; Ma C
J Am Heart Assoc; 2023 Aug; 12(16):e029623. PubMed ID: 37548160
[TBL] [Abstract][Full Text] [Related]
19. Sodium-glucose co-transporter-2 inhibitors for the prevention of atrial fibrillation: a systemic review and meta-analysis.
Zhang HD; Ding L; Mi LJ; Zhang AK; Zhang K; Jiang ZH; Yu FY; Yan XX; Shen YJ; Tang M
Eur J Prev Cardiol; 2024 May; 31(7):770-779. PubMed ID: 37966828
[TBL] [Abstract][Full Text] [Related]
20. Association of SGLT2 Inhibitors With Risk of Atrial Fibrillation and Stroke in Patients With and Without Type 2 Diabetes: A Systemic Review and Meta-Analysis of Randomized Controlled Trials.
Zheng RJ; Wang Y; Tang JN; Duan JY; Yuan MY; Zhang JY
J Cardiovasc Pharmacol; 2022 Feb; 79(2):e145-e152. PubMed ID: 34813574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
